Latest Comparison,Hims has sold compounded versions of the weight-loss drugs

The landscape of weight management has seen significant advancements, with semaglutide emerging as a prominent player. For individuals seeking solutions, particularly through platforms like Hers, understanding compounded semaglutide is crucial. This article delves into the specifics of compounded semaglutide Hers offers, exploring its nature, potential benefits, associated risks, and cost considerations, while also touching upon the broader context of semaglutide medications.

What is Compounded Semaglutide?

Unlike FDA-approved medications that are manufactured in a standardized way by a single pharmaceutical company, compounded semaglutide is prepared by compounding pharmacies. These pharmacies create custom medications based on a prescriber's order. In the context of Hers, this means they may offer compounded versions of semaglutide. While the active ingredient is intended to be semaglutide, the exact formulation, purity, and inactive ingredients can vary between compounding pharmacies. This is a key distinction from FDA-approved drugs like Wegovy, a brand-name semaglutide medication, which undergoes rigorous testing for safety and efficacy. The compounded formulations are not FDA-approved, meaning the agency does not review their safety and efficacy in the same way.

Hers and Semaglutide Offerings

Hims & Hers has been a notable provider in the telehealth space, offering various wellness programs. In their weight loss offerings, they have provided access to semaglutide. For instance, a Hers online GLP-1 clinic review indicates that patients can start for as low as $199/month for compounded options. They also offer programs that may include semaglutide starting at $199 a month for a 6-month plan paid upfront. It's important to note that Hims & Hers has entered into an agreement with Novo Nordisk, the manufacturer of Ozempic and Wegovy, which may influence their future offerings. However, there have been instances where Hims & Hers plans to launch a $49 compounded semaglutide pill or similar low-cost options, which have faced scrutiny and, in some cases, withdrawal. For example, Hims & Hers has withdrawn its $49 compounded semaglutide pill after pressure from health officials.

Eligibility and Dosage Considerations

To qualify for semaglutide for weight loss, specific criteria typically need to be met. Generally, individuals need to have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition. The semaglutide dose for weight loss is carefully managed, with the maximum dose commonly cited as 2.4 mg for Wegovy®. Dosing schedules for semaglutide usually involve a gradual increase over time to help manage potential side effects and improve tolerance. Understanding the effectiveness, dosing, side effects is paramount for any patient considering these treatments.

Potential Risks and Safety Concerns

The use of compounded semaglutide is not without its potential risks to consider. Because these formulations are not FDA-approved, there's a lack of standardized oversight. Concerns have been raised about the actual active ingredients present in some compounded versions. For example, some compounded preparations contain unapproved ingredients, such as semaglutide sodium or semaglutide acetate. This has led to a class action lawsuit alleging that Hims & Hers compounded semaglutide GLP-1 does not contain the same active ingredients as Ozempic. Furthermore, reports have surfaced linking compounded versions of semaglutide to hospitalizations and even deaths. Novo Nordisk calls out dangers of compounded GLP-1s, highlighting these risks. It is vital for individuals to be aware that Hims/hers is compounded, meaning it's not subject to the same regulatory scrutiny as FDA-approved drugs. Therefore, Hers compounded semaglutide safety is a significant consideration that patients should thoroughly discuss with their healthcare provider.

Cost and Alternatives

The cost of semaglutide can vary significantly. While Hims has sold compounded versions of the weight-loss drugs, sometimes at lower price points, the cost of FDA-approved options can be substantial without insurance. For example, Wegovy, a brand-name semaglutide medication, can have prices starting at $149 per month for the pill and $199 for the injectable pen, with other plans being $199 if you sub for 12 months. Without insurance coverage, the cost of Wegovy can be considerably higher compared to some compounded semaglutide options that were offered at prices like $50 per month. Hers offers access to semaglutide starting at $199 a month on a 6-month plan. However, it's also important to note that **Hims & Hers said on Monday that it may no longer be